Low-affinity receptor-mediated induction of superoxide by N-formyl-Methionyl-Leucyl-Phenylalanine and WKYMVm in IMR90 human fibroblasts

Free Radical Biology and Medicine

Volumn 36, Issue 2, 2004, Pages 189-200

  Ammendola, Rosario ^a,b   Russo, Lucia ^a   De Felice, Carmela ^a   Esposito, Franca ^a   Russo, Tommaso ^a   Cimino, Filiberto ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Extracellular signal regulated kinases; Formyl peptide receptors; Free radicals; Human fibroblasts; NADPH oxidase; p47phox; Reactive oxygen species

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; COMPLEMENTARY DNA; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE; G PROTEIN COUPLED RECEPTOR; IODINE 125; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PEPTIDE DERIVATIVE; PERTUSSIS TOXIN; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITY; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOLECULE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SIGNAL TRANSDUCTION;

EID: 1642546347     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.10.015     Document Type: Article

References (75)

1. Babior B.M. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:1978;659-668.
2. Hayakawa T., Suzuki K., Suzuki S., Andrews P.C., Babior B.M. A possible role for protein phosphorylation in the activation of the respiratory burst in human neutrophils: evidence from studies with cells from patients with chronic granulomatous disease. J. Biol. Chem. 261:1986;9109-9115.
3. Okamura N., Curnutte J.T., Roberts R.L., Babior B.M. Relationship of protein phosphorylation to the activation of the respiratory burst in human neutrophils: defects in the phosphorylation of a group of closely related 48-kDa proteins in two forms of chronic granulomatous disease. J. Biol. Chem. 263:1988;6777-6782.
4. Rotrosen D., Leto T.L. Phosphorylation of neutrophil 47-kDa cytosolic oxidase factor: translocation to membrane is associated with distinct phosphorylation events. J. Biol. Chem. 265:1990;19910-19915.
5. Babior B.M. NADPH oxidase: an update. Blood. 93:1999;1464-1473.
6. El Benna J., Han J., Park J.W., Schmid E., Ulevitch R.J., Babior B.M. Activation of p38 in stimulated human neutrophils: phosphorylation of the oxidase component p47phox by p38 and ERK but not by JNK. Arch. Biochem. Biophys. 334:1996;395-400.
7. El Benna J., Faust L.P., Babior B.M. The phosphorylation of the respiratory burst oxidase component p47phox during neutrophil activation: phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J. Biol. Chem. 269:1994;23431-23436.
8. Dang P.M.-C., Fontayne A., Hakim J., El Benna J., Perianin A. Protein kinase C zeta phosphorylates a subset of selective sites of the NADPH oxidase component p47phox and participates in formyl peptide-mediated neutrophil respiratory burst. J. Immunol. 166:2001;1206-1213.
9. Fontayne A., Dang P.M.-C., Goucerot-Pocidalo M.-A., El Benna J. Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry. 41:2002;7743-7750.
10. Dewas C., Fay M., Gougerot-Pocidalo M.A., El-Benna J. The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils. J. Immunol. 165:2000;5238-5244.
11. Knaus U.G., Morris S., Dong H.J., Chernoff J., Bokoch G.M. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science. 269:1995;221-223.
12. Suh Y.-A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 401:1999;79-82.
13. Munzel T., Hink U., Heitzer T., Meinertz T. Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann. NY Acad. Sci. 874:1999;386-400.
14. Moulton P.J., Goldring M.B., Hancock J.T. NADPH oxidase of chondrocytes contains an isoform of the gp91phox subunit. Biochem. J. 329:1998;449-451.
15. Ammendola R., Ruocchio M.R., Chirico G., Russo L., De Felice C., Esposito F., Russo T., Cimino F. Inhibition of NADH/NADPH oxidase affects signal transduction by growth factor receptors in normal fibroblasts. Arch. Biochem. Biophys. 397:2002;253-257.
16. Yang S., Madyashtha P., Bingel S., Ries W., Key L. A new superoxide-generating oxidase in murine osteoclasts. J. Biol. Chem. 276:2000;5452-5458.
17. Gorlach A., Brandes R.P., Nguyen K., Amidi M., Dehghani F., Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87:2000;26-32.
18. Tammariello S.P., Quinn M.T., Estus S. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J. Neurosci. 20:2000;RC53.
19. De Deken X., Wang D., Many M.C., Costagliola S., Libert F., Vassart G., Dumont J.E., Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J. Biol. Chem. 275:2000;23227-23233.
20. Geiszt M., Kopp J.B., Varnai P., Leto T.L. Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. USA. 97:2000;8010-8014.
21. Shiose A., Kuroda J., Tsuruya K., Hirai M., Hirakata H., Naito S., Hattori M., Sakaki Y., Sumimoto H. A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276:2001;1417-1423.
22. 2+-activated NADPH oxidase in testis, spleen, and lymph nodes. J. Biol. Chem. 276:2001;37594-37601.
23. Mizuki K., Kadomatsu K., Hata K., Ito T., Fan Q.-W., Kage Y., Fukumaki Y., Sakaki Y., Takeshige K., Sumimoto H. Functional modules and expression of mouse p40(phox) and p67(phox), SH3-domain-containing proteins involved in the phagocyte NADPH oxidase complex. Eur. J. Biochem. 251:1998;573-582.
24. Chabrashvili T., Tojo A., Onorato M.L., Kitiyakara C., Quinn M.T., Fujita T., Welch W.J., Wilcox C.S. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension. 39:2002;269-274.
25. Banfi B., Clark R.A., Steger K., Krause K.H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278:2003;3510-3513.
26. Hohler B., Holzapfel B., Kummel W. NADPH oxidase subunits and superoxide production in porcine pulmonary artery endothelial cells. Histochem. Cell Biol. 114:2000;29-37.
27. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., Pagano P.J., Schiffrin E.L. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ. Res. 90:2002;1205-12313.
28. Schiffmann E., Corcoran B.A., Wahl S.M. N-Formylmethionyl peptides as chemoattractants for leucocytes. Proc. Natl. Acad. Sci. USA. 72:1975;1059-1062.
29. Prossnitz E.R., Ye R.D. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74:1997;73-81.
30. Murphy P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:1994;593-633.
31. Murphy P.M., McDermott D. Functional expression of the human formyl peptide receptor in Xenopus oocytes requires a complementary human factor. J. Biol. Chem. 266:1991;12560-12567.
32. Boulay F., Tardif M., Brouchon L., Vignais P. The human N-formylpeptide receptor: characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry. 29:1990;11123-11133.
33. Boulay F., Tardif M., Brouchon L., Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem. Biophys. Res. Commun. 168:1990;1103-1109.
34. Murphy P.M., Ozcelik T., Kenney R.T., Tiffany H.L., McDermott D., Francke U. A structural homologue of the N-formyl peptide receptor: characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267:1992;7637-7643.
35. Ye R.D., Cavanagh S.L., Quehenberger O., Prossnitz E.R., Cochrane C.G. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184:1992;582-589.
36. Bao L., Gerard N.P., Eddy R.L. Jr., Shows T.B., Gerard C. Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics. 13:1992;437-440.
37. Fiore S., Maddox J.F., Peres H.D., Serhan C.N. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 180:1994;253-259.
38. Becker E.L., Forouhar F.A., Grunnet M.L., Boulay F., Tardif M., Bormann B.J., Sodja D., Ye R.D., Woska J.R. Jr., Murphy P.M. Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res. 292:1998;129-135.
39. McCoy R., Haviland D.L., Molmenti E.P., Ziambras T., Wetsel R.A., Permutter D.H. N-Formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J. Exp. Med. 182:1995;207-217.
40. Rescher U., Danielczyk A., Markoff A., Gerke V. Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J. Immunol. 169:2002;1500-1504.
41. Le Y., Hu J., Gong W., Shen W., Li B., Dunlop N.M., Halverson D.O., Blair D.G., Wang J.M. Expression of functional formyl peptide receptors by human astrocytoma cell lines. J. Neuroimmunol. 111:2000;102-108.
42. Keitoku M., Kohzuki M., Katoh H., Funakoshi M., Suzuki S., Takeuchi M., Karibe A., Horiguchi S., Watanabe J., Satoh S., Nose M., Abe K., Okayama H., Shirato K. FMLP actions and its binding sites in isolated human coronary arteries. J. Mol. Cell. Cardiol. 29:1997;881-894.
43. Tiffany H.L., Lavigne M.C., Cui Y.H., Wang J.M., Leto T.L., Gao J.L., Murphy P.M. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J. Biol. Chem. 276:2001;23645-23652.
44. Baek S.H., Seo J.K., Chae C.-B., Suh P.-G., Ryu S.H. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J. Biol. Chem. 271:1996;8170-8175.
45. Seo J.K., Choi S.Y., Kim Y., Baek S.H., Kim K.T., Chae C.-B., Lambeth J.D., Suh P.-G., Ryu S.H. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J. Immunol. 158:1997;1895-1901.
46. Bae Y.S., Ju S.A., Kim J.Y., Seo J.K., Baek S.H., Kwak J.Y., Kim B.S., Suh P.-G., Ryu S.H. Trp-Lys-Tyr-Met-Val-D-Met stimulates superoxide generation and killing of Staphylococcus aureus via phospholipase D activation in human monocytes. J. Leukoc. Biol. 65:1999;241-248.
47. Le Y., Gong W., Li B., Dunlop N.M., Shen W., Su S.B., Ye R.D., Wang J.M. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl receptor, by the synthetic hexapeptide WKY MVm for human phagocyte activation. J. Immunol. 163:1999;6777-6784.
48. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
49. Cross A.R., Higson F.K., Jones O.T.G. The enzymic reduction and kinetics of oxidation of cytochrome b-245 of neutrophils. Biochem. J. 204:1982;479-485.
50. Robinson L.J., Pang S., Harris D.S., Heuser J., James D. Translocation of the glucose transporter (GLUT4) to the cell surface in permeabilized 3T3-L1 adipocytes: effects of ATP, insulin and GTP-γ-S and localization of GLUT4 to clathrin lattices. J. Cell Biol. 117:1992;1181-1196.
51. Kreuzer J., Viedt C., Brandes R.P., Seeger F., Rosenkranz A.S., Sauer H., Babich A., Nurnberg B., Kather H., Krieger-Brauer H.I. Platelet-derived growth factor activates production of reactive oxygen species by NAD(P)H-oxidase in smooth muscle cells through Gi1,2. FASEB J. 17:2003;38-40.
52. Heyworth P.G., Curnutte J.T., Nauseef W.M., Volpp B.D., Pearson D.W., Rosen H., Clark R.A. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly: translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J. Clin. Invest. 87:1991;352-356.
53. Kleinberg M.E., Malech H.L., Miatl D.A., Leto T.L. p21rac does not participate in the early interaction between p47-phox and cytochrome b558 that leads to phagocyte NADPH oxidase activation in vitro. Biochemistry. 33:1994;2490-2495.
54. Cross A.R. Inhibitors of the leukocyte superoxide generating oxidase: mechanisms of action and methods for their elucidation. Free Radic. Biol. Med. 8:1990;71-93.
55. Torres M., Hall F.L., O'Neill K. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanineinduces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J. Immunol. 150:1993;1563-1577.
56. Grinstein S., Furuya W. Chemoattractant-induced tyrosine phosphorylation and activation of microtubule-associated protein kinase in human neutrophils. J. Biol. Chem. 267:1992;18122-18125.
57. Yu H., Suchard S.J., Nairn R., Jove R. Dissociation of mitogen-activated protein kinase activation from the oxidative burst in differentiated HL-60 cells and human neutrophils. J. Biol. Chem. 270:1995;15719.
58. Pillinger M.H., Feoktistov A.S., Capodici C., Solitar B., Levy J., Oei T.T., Philips M.R. Mitogen-activated protein kinase in neutrophils and enucleate neutrophil cytoplasts: evidence for regulation of cell-cell adhesion. J. Biol. Chem. 271:1996;12049-12056.
59. Quehenberger O., Prossnitz E.R., Cavanagh S.L., Cochrane C.G., Ye R.D. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. J. Biol. Chem. 268:1993;18167-18175.
60. 4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 276:2001;21585-21593.
61. Colquhoun D. Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. Br. J. Pharmacol. 125(5):1998;924-947.
62. Yue Hu J., Le Y., Gong W., Dunlop N.M., Gao J.L., Murphy P.M., Wang J.M. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukoc. Biol. 70:2001;155-161.
63. Klein C., Paul J.I., Sauvé K., Schmidt M.M., Arcangeli L., Ransom J., Truherat J., Manfredi J.P., Broach J.R., Murphy A.J. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat. Biotechnol. 16:1998;1334-1337.
64. Deng X., Ueda H., Su S.B., Gong W., Dunlop N.M., Gao J., Murphy P.M., Wang J.M. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. Blood. 94:1999;1165-1173.
65. Su S.B., Gao J., Gong W., Dunlop N.M., Murphy P.M., Oppenheim J.J., Wang J.M. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. J. Immunol. 162:1999;5924-5930.
66. Su S.B., Gong W., Gao J.L., Shen W., Murphy P.M., Oppenheim J.J., Wang J.M. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189:1999;395-402.
67. Filomeni G., Rotilio G., Ciriolo M.R. Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 MAP kinase pathway. FASEB J. 17:2003;64-66.
68. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
69. Resnati M., Pallavicini I., Wang J.M., Oppenheim J., Serhan C.N., Blasi F. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. USA. 99:2002;1359-1364.
70. Jones S.A., Wood J.D., Coffey M.J., Jones O.T.G. The functional expression of p47-phox and p67-phox may contribute to the generation of superoxide by an NADPH oxidase-like system in human fibroblasts. FEBS Lett. 355:1994;178-182.
71. Lal A.S., Clifton A.D., Rouse J., Segal A.W., Cohen P. Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38. Biochem. Biophys. Res. Commun. 259:1999;465-470.
72. Nick J.A., Avdi N.J., Young S.K., Knall C., Gerwins P., Johnson G.L., Worthen G.S. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 99:1997;975-986.
73. Benna J.E., Dang P.M.-C., Gaudry M., Fay M., Morel F.F., Hakim J., Gougerot-Pocidalo M.-A. Phosphorylation of the respiratory burst oxidase subunit p67(phox) during human neutrophil activation: regulation by protein kinase C-dependent and independent pathways. J. Biol. Chem. 272:1997;17204- 17208.
74. Curnutte J.T. Molecular basis of the autosomal recessive forms of chronic granulomatous disease. Immunol. Rev. 3:1992;149-172.
75. Banfi B., Clark R.A., Steger K., Krause K.-H. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278:2003;3513-3570.